Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilofexor in Primary Sclerosing Cholangitis (PSC)
NCT02943460Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2016
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of cilofexor in Primary Sclerosing Cholangitis (PSC), sponsored by Gilead Sciences. Started Nov 2016; status: completed.
02
Drugs
cilofexor
03
Conditions
Primary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on NCT02943460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943460.